Профессор Сулейман Алиджи MD
Онколог
Госпиталь Алтунизаде
Образование
2004 г.Yüzüncü YılUniversity – медицинский факультет/ассоциированный профессор
2000 г. Стамбульский Университет, Стамбульского медицинского факультета медицинская онкология
1996 г.Yüzüncü YılUniversity – медицинский факультет/ассистент профессор
1995 г.медицинский факультет Сельчукского Университета, внутренняя медицина
1990 г. Медицинский факультет Ататурского Университета
Опыт работы
С 2017 по сегодняшний день AcıbademHealthGroup
2013-2016 университет Бахчешехир, факультет медицины MedicalparkGöztepeHospital/врач-профессор
2008 г. - Göztepe Medicalpark Hospital-а раковой клиники/ассоциированный профессор
2007 Dana Farber Cancer Institute, Boston-USA (опухоли молочной железы и желудочно-кишечного тракта и тренинг опухоли груди)
2005-2008 гг. Министерство здравоохранения, Анкаринская научная и учебная больница Ататурка, медицинской онкологической клиники/руководитель клиники
2004 - 2005 Yüzüncü Yıl University департамент внутренних заболеваний медицинского факультета/ассоциированный профессор
1996 - 2004 Yüzüncü Yıl University департамент внутренних заболеваний факультета медицины/ассистент профессор врач
1991 г. Центр здоровья Генчека
1991-1995 гг. – университет Сельчука, факультет медицины, департамент внутренних болезней
MEMBERSHIPS
- Gastrointestinal Tumors Association (founding member)
- Turkish Oncology Group
- American Society of Clinical Oncology (ASCO)
- Clinical Oncology Association (founding member)
- Medical Research Association (founding member)
- European Society of Medical Oncology (ESMO)
- Medical Oncology Association
- Lung Cancer Association (founding member)
- Anatolian Medical Oncology Association (founding member)
PUBLICATIONS
- Synovial sarcoma with multiple vertebrae metastases causing multilevel thoracic spinal cord compressions.Spine J. 2016 Jun; 16 (6): e363-4. doi: 10.1016 / j.spinee.2015.11.063. Epub 2015 Dec 8. No abstract available. Demir MK, Fakir E, Furuncuoglu Y, Alı S, Argon A, Koca S.
- Predictive and prognostic values of BubR1 and synuclein-gamma expression in breast cancer.Int J Clin Exp Pathol. 2015 May 1; 8 (5): 5345-53. eCollection 2015. Cirak Y, Furuncuoglu Y, Yapicier O, Alici S, Argon A.
- Value of caffeic acid phenethyl ester pretreatment in experimental sepsis model in rats.Mediators Inflamm. 2015; 2015: 810948. doi: 10.1155 / 2015/810948. Epub 2015 Apr 8. Alici O, Kavakli HS, Koca C, Altintas ND, Aydin M, Alici S
- Pathologic and clinical characteristics of elderly patients with breast cancer: a retrospective analysis of a multicenter study (anatolian society of medical oncology)G, Dogu GG, Engin H, Unal OU, Tamozlu T, Buyukberber S, Boruban CM, Isıkdogan / Int Surg. 2014 Jan-Feb; 99 (1): 2-7 Inal A, Akman T, Yaman S, Ozturk SC, Geredeli C, Bilici M, Inanc M, Harputoglu H, Demirci U, Balakan O, Cınkır HY, Receiver S, Colak D, Sonmez OU, Goksel
- Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical OncologyInanc M, Elkiran ET, Ozdemir NY, Durnalı AG, Suner A, Alici S, Tarhan MO, Boruban C, Oksuzoglu B, Urakci Z. with those who received trastuzumab-based Kaplan MA, Isikdogan A, Koca D, Kucukoner M, Gumusay O, Yildiz R, Dayan A, Demir L, Geredeli C, Kocer M, Arslan UY, Inal A, Akman T, Coskun U, Sener N
- Treatment and prognostic factors in primary peritoneal carcinoma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)Oncol Res Treat. 2014; 37 (6): 332-8. Unal OU, Oztop I, Yazici O, Ozatli T, Inal A, Günaydın Y, Alici S, Demirci U, Cinkir HY, Aktas B, Aslan K, Uncu D, Yilmaz AU, Oksuzoglu B, Buyukberber
- Is lymph node ratio prognostic factor for survival in elderly patients with node positive breast cancer? The Anatolian Society of Medical Oncology.Dogu GG, Engin H, Unal OU, Tamozlu T, Buyukberber S, Boruban CM, Isıkdogan A. Ann Ital Chir. 2013 Mar-Apr; 84 (2): 143-8. Inal A, Akman T, Yaman S, Ozturk SC, Geredeli C, Bilici M, Inanc M, Harputoglu H, Demirci U, Suner A, Cınkır HY, Receiver S, Colak D, Sonmez OU, Goksel G
- Endocrine therapy alone vs. chemotherapy plus endocrine therapies for the treatment of elderly patients with endocrine-responsive and node positive breast cancer: a retrospective analysis of a multicenter study (Anatolian Society of Medical Oncology)Goksel G, Gokoz Dogu G, Umit Unal O, Tamozlu T, Buyukberber S, Melih Boruban C, Isikdogan AJ BUON. 2013 Jan-Mar; 18 (1): 64-9. Inal A, Akman T, Yaman S, Demir Ozturk S, Geredeli C, Bilici M, Inanc M, Harputoglu H, Demirci U, Balakan O, Yesil Cinkir H, Alici S, Uysal Sonmez O,
- Salvage treatment experience in advanced synovial sarcoma: a multicenter retrospective analysis of the Anatolian society of medical oncologyAsian Pac J Cancer Prev. 2013; 14 (9): 5185-8. Yetisyigit T, Arpaci E, Seber ES, Kucukoner M, Kos FT, Sonmez OU, Alici S, Akman T, Aktas B, Yildiz R, Gunaydin Y, Inanc M, Demirci U, Alkis N, Gumus
- Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences.Asian Pac J Cancer Prev. 2013; 14 (11): 6287-92. Oven Ustaalioglu BB, Unal OU, Turan N, Bilici A, Kaya S, Eren T, Ulas A, Inal A, Berk V, Demirci U, Alici S, Bal O, Benekli M, Gumus M.
